Naproxen sodium-induced toxic epidermal necrolysis: A case report and review of the literature

European Surgery - Acta Chirurgica Austriaca

Volumn 37, Issue 6, 2005, Pages 343-347

  Kalemoglu, Murat ^a   Keskin, O ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Adverse drug reactions; Lyell syndrome; Naproxen sodium; Toxic epidermal necrolysis

Indexed keywords

NAPROXEN;

ACUTE DISEASE; AGED; CASE REPORT; DISEASE ASSOCIATION; EMERGENCY WARD; EPIDERMIS; EROSION; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MUCOSA INFLAMMATION; PATIENT MONITORING; PRURITUS; RASH; REVIEW; SCAR FORMATION; SURVIVAL; TOXIC EPIDERMAL NECROLYSIS; WOUND CARE;

EID: 30744450265     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10353-005-0194-8     Document Type: Review

References (29)

1. Yarbrough DR III (1996) Experience with toxic epidermal necrolysis treated in a burn center. J Burn Care Rehabil 17: 30-33
2. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau CJ (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129: 92-96
3. Avakian R, Flowers F, Araujo O, Ramos-Caro F (1991) Toxic epidermal necrolysis: a review. J Am Acad Dermatol 25: 69-79
4. Hermes B, Haas N, Henz BM (1996) Plasmapheresis and immunopathogenic aspects of toxic epidermal necrolysis [in German]. Hautarzt 47: 749-753
5. Breathnach SM, Mc Gibbon DH, Ive FA, Black MM (1982) Carbamazepine and toxic epidermal necrolysis: report of three cases with histopathological observations. Clin Exp Dermatol 7: 585-591
6. Peck GL, Elias PM, Graw RG Jr (1972) Graft-versus-host reaction and toxic epidermal necrolysis. Lancet 2: 1151-1153
7. Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, Touraine R (1987) Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol 123: 1160-1165
8. Roujeau J, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schöpf E, Kaufman DW (1995) Medication use and the risk of Stevens Johnson syndrome or toxic epidermolysis. N Engl J Med 333: 1600-1607
9. Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R (1987) The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 123: 1166-1170
10. Chan HL, Stem RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM (1990) The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermolysis. Arch Dermatol 126: 43-47
11. Fritsch PO, Ruiz-Maldonado R (1999) Stevens-Johnson syndrome-toxic epidermolysis. In: Freedberg IM (ed) Fitzpatrick's dermatology in general medicine. New York, McGraw-Hill, pp 1080-1086
12. Araujo OE, Flowers FP (1984) Stevens-Johnson syndrome. J Emerg Med 2: 129-135
13. Paul C, Wolkenstein P, Adle H, Wechsler J, Garchon HJ, Revuz J, Roujeau JC (1996) Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134: 710-714
14. Roujeau J, Chosidow O, Saiag P, Guillaume JC (1990) Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 23: 1039-1058
15. Ellis MW, Oster CN, Turiansky GW, Blanchard JR (2002) A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center. Mil Med 8: 701-704
16. David SB (1998) Toxic epidermal necrolysis. Lancet 351: 1417-1424
17. Nasser M, Bitterman-Deutsch O, Nassar F (2005) Intravenous immunoglobulin for treatment of toxic epidermal necrolysis. Am J Med Sci 329: 95-98
18. Ducic I, Shalom A, Rising W, Nagamoto K, Munster A (2002) Outcome of patients with toxic epidermal necrolysis syndrome revisited. Plast Reconstr Surg 110: 768-773
19. Galindo EC, Bujan JG, Suva JM et al (2004) Fixed drug eruption from piroxicam. J Eur Acad Dermatol Venereol 18: 586-587
20. Bastuji-Garin S, Rzany B, Stern R, Shear NH, Naldi L, Roujeau JC (1966) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129: 92-96
21. Krumlovsky F, Del Greco F, Herdson P, Lazar P (1974) Renal disease associated with toxic epidermal necrolysis (Lyell's disease). Am J Med 57: 817-825
22. Prins C, Kerdel FA, Padilla RS, Hunziker T, Cimenti S, Viard I, Mauri DN, Flynn K, Trent J, Margolis DJ, Saurat JH, French LE, TEN-IVIG Study Group (2003) Treatment of toxic epidermal necrolysis with high dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 139: 26-32
23. Trent J, Kirsner RS, Romanelli P, Kerdel FA (2003) Analysis of intravenous immunoglobulin for treatment of toxic epidermal necrolysis using SCORTEN. Arch Dermatol 1398: 39-3
24. Fish JS (2003) Toxic epidermal necrolysis: the role of burn units in treating these massive cutaneous wounds. Probl Gen Surg 20: 120-128
25. Halebian P, Corder VJ, Madden MR, Finklestein JL, Shires GT (1986) Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 204: 503-512
26. Haber J, Hopman W, Gomez M, Cartotto R (2005) Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center. J Burn Care Rehabil 26: 33-41
27. Stables G, Lever R (1993) Toxic epidermal necrolysis and systemic corticosteroids. Br J Dermatol 128: 357-360
28. Rzany B, Schmitt H, Schopf E (1991) Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol 71: 171-172
29. Shortt RB, Gomez M, Mittman N, Cartotto R (2004) Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis. J Burn Care Rehabil 25: 246-255